Werewolf Therapeutics, Inc.
HOWL· Nasdaq
Werewolf Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +5.34%
- Market cap
- $45.15M
- 48.6M shares
- Filings
- 449
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,830,000 | reported | |
| FY 2024 | 2024-12-31 | $56,434,000 | reported | |
| FY 2023 | 2023-12-31 | $41,776,000 | reported | |
| FY 2022 | 2022-12-31 | $53,761,000 | reported | |
| FY 2021 | 2021-12-31 | $35,269,000 | reported | |
| FY 2020 | 2020-12-31 | $16,641,000 | reported |
Werewolf Therapeutics, Inc. · CIK 1785530 · Engraved from SEC EDGAR
